Hodgkin-limfóma: vizsgálatok itt: Franciaország
22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Where
- Paris, Villejuif
- Életkor
- 6 hónap to 17 év
- People
- 370 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00 - 1/2. fázisTaking peopleA Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Where
- Clermont-Ferrand, Dijon, Montpellier Cedex 5, Nice, Paris
- Életkor
- 18 év and over
- People
- 280 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07519772 · EU 2025-523005-15-00 - 1/2. fázisFut, nem toborozAn early study to investigate a new medicine for Subjects with Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
- Where
- Bordeaux, Creteil Cedex, Lille, Montpellier Cedex 5, Paris, Pierre-Bénite, Rouen Cedex, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 204 worldwide
- Run by
- Celgene Corp.
See details and how to joinNCT03930953 · EU 2024-515690-10-00 - 2. fázisTaking peopleStudy of MEN1703 in Patients with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
- Where
- Le Mans Cedex 9, Lille, Limoges, Montpellier Cedex 5, Paris, Pessac, Pierre-Bénite
- Életkor
- 18 év and over
- People
- 118 worldwide
- Run by
- Ryvu Therapeutics S.A.
See details and how to join2024-513098-31-00 - 2. fázisTaking peopleEvaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Where
- Grenoble Cedex 9, Montpellier Cedex 5, Pessac, Rennes Cedex 9, Tours Cedex 9
- Életkor
- 18 év and over
- People
- 130 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06806033 · EU 2024-516791-15-00 - 1/2. fázisTaking peopleA Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma
- Where
- Bordeaux, Villejuif
- Életkor
- Up to 17 év
- People
- 37 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2023-504264-41-00 - 1. fázisTaking peopleA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Lille, Marseille, Nantes, Paris, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - 1. fázisVisszavonvaA Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Where
- Nantes, Paris, Pessac, Pierre-Bénite, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07226843 · EU 2025-523601-16-00 - 1. fázisNot yet taking people in FranciaországA Study of ARC-02 in B-cell NHL
- Where
- Creteil Cedex, Lille, Nantes, Pierre-Bénite, Villejuif Cedex
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07691606 · EU 2026-525606-35-00 - 1/2. fázisFut, nem toborozA Phase 1/2a Study of UCART20x22 in B-Cell Non-Hodgkin Lymphoma [NatHaLi-01]
- Where
- Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Pessac, Pierre-Bénite, Toulouse Cedex 9, Vandoeuvre Les Nancy, Villejuif
- Életkor
- 18 év and over
- People
- 48 worldwide
- Run by
- Cellectis
See details and how to joinNCT05607420 · EU 2022-501607-27-00 - 2. fázisTaking peopleSurovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
- Where
- Montpellier Cedex 5, Paris Cedex 10, Pierre-Bénite, Rouen Cedex
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06526793 · EU 2023-505789-27-00 - 1/2. fázisTaking peopleAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
- Where
- Créteil, Dijon, Lille, Pierre-Bénite, Villejuif
- Életkor
- 12 év and over
- People
- 161 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137144 · EU 2023-506747-42-00 - 3. fázisNot yet taking people in FranciaországA Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Where
- Brest, Nantes Cedex 2, Tours
- Életkor
- 18 év and over
- People
- 49 worldwide
- Run by
- Grifols Biologicals, LLC
See details and how to joinNCT07582432 · EU 2026-526803-31-00 - 1/2. fázisTaking peopleA study to evaluate safety and clinical activity of GSK5926371 in adult participants with relapsed or refractory B-NHL
- Where
- Pierre-Bénite, Rennes, Villejuif
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- Glaxosmithkline Research & Development Limited
See details and how to join2025-524915-36-00 - 2. fázisTaking peopleFaecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
- Where
- Amiens, Angers, Besançon, Clermont-Ferrand, Grenoble, Lille, Limoges, Lyon, Nancy, Nantes, Nice, Paris, Pessac, Poitiers, Rouen, Saint-Etienne, Toulouse
- Életkor
- 18 év and over
- People
- 150
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT04935684 - 1. fázisTaking peopleA Trial to Study if REGN5837 in Combination with Odronextamab is Safe for Adult Participants with Aggressive B-cell Non-Hodgkin Lymphomas
- Where
- Paris, Pessac, Villejuif
- Életkor
- 18 év and over
- People
- 42 worldwide
- Run by
- Regeneron Pharmaceuticals Inc.
See details and how to joinNCT05685173 · EU 2022-502137-26-00 - No phaseTaking peopleProspective Cohort With Hemopathy in Languedoc-Roussillon
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 500
- Run by
- University Hospital, Montpellier
See details and how to joinNCT02134574 - 4. fázisTaking peopleETCABio - Evaluation of Skin Tests in Biotherapy Allergies
- Where
- Angers
- Életkor
- 18 év and over
- People
- 140
- Run by
- Centre Hospitalier Universitaire D'Angers
See details and how to join2024-519812-15-00 - 2/3. fázisNot yet taking people in FranciaországA Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
- Where
- Bordeaux Cedex, Lyon Cedex 08, Villejuif
- Életkor
- Up to 25 év
- People
- 210 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT05991388 · EU 2024-510575-38-00 - 1. fázisTaking peopleStudy of SGR-1505 in Mature B-Cell Neoplasms
- Where
- Creteil Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 98 worldwide
- Run by
- Schrödinger, Inc.
See details and how to joinNCT05544019 · EU 2023-505204-34-00 - No phaseNot yet taking people in FranciaországHodgkin's Disease and Chemotherapy Before 40 Years
- Where
- Arras, Lille, Lomme, Roubaix
- Életkor
- 18 év to 40 év
- People
- 63
- Run by
- Lille Catholic University
See details and how to joinNCT06116929 - No phaseTaking peopleREal World Data in LYmphoma and Survival in Adults
- Where
- Arras, Besançon, Bordeaux, Bourgoin, Caen, Chambéry, Clermont-Ferrand, Créteil, Dijon, Dunkirk, Grenoble, La Roche-sur-Yon, La Tronche, Le Mans, Libourne, Lille, Limoges, Lyon, Montpellier, Mulhouse, Nantes, Niort, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Roubaix, Rouen, Saint-Brieuc, Saint-Cloud, Saint-Priest-en-Jarez, Strasbourg, Toulouse, Vannes
- Életkor
- 18 év and over
- People
- 6000
- Run by
- Hospices Civils de Lyon
See details and how to joinNCT03869619